ZBH - Gunggunge utang jangka dawa zimmerbiomet.com

Tandha merek Zimmer Biomet (ZBH)

Stable demand for prosthetics driven by an aging population provides Zimmer Biomet Holdings (ZBH) with a consistent cash flow. The company's long-term debt history reflects credit load dynamics, where 6.42 serves as the base parameter value. The effective implementation of ROSA robotics supports margins, although global logistical disruptions and sanctions limit access to rare alloys, narrowing the corporation's target markets.

ZBH Zimmer Biomet Corp: Utang jangka dawa perusahaan ing interval 04.07.2022 - 01.11.2026
Produk mawa merek Zimmer

Long-term debt reflects the total credit obligations of the company with a maturity exceeding one year. This metric measures the sustainability of financial leverage, allowing investors to assess default risks through the volume of the business's long-term borrowed capital. A decrease in this indicator signals an increase in the issuer's autonomy. For Zimmer Biomet Holdings (ZBH), such stability is critical, as insurmountable technological barriers and patents ensure a steady cash flow to service borrowings.

Karo sapa Zimmer Biomet Holdings saingan

BSX - Kewajiban jangka dawa perusahaan|Edwards Lifesciences Corporation - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa ResMed Inc RMD|PODD: Utang jangka dawa perusahaan|CooperSurgical (COO) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Align Technology, Inc.|Utang jangka dawa perusahaan GMED|Utang jangka dawa perusahaan TMDX|Gunggunge utang jangka dawa Alphatec Holdings|Artivion Inc - Kewajiban jangka dawa perusahaan|ENOV (Enovis Inc.) - Kewajiban jangka dawa|Integra LifeSciences - Utang jangka dawa perusahaan|Utang jangka dawa establishmentlabs.com|BBNX: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan IRMD|Kewajiban jangka dawa perusahaan EMBC|TNDM: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan AxoGen, Inc. (AXGN)|Kewajiban jangka dawa perusahaan si-bone.com SIBN|Utang jangka dawa perusahaan OFIX (Orthofix)|Bioventus Inc (BVS) - Utang jangka dawa|OrthoPediatrics Inc. - Utang jangka dawa perusahaan|TMCI (Treace Corp) - Tanggungan utang jangka dawa perusahaan|SRTA: Utang jangka dawa perusahaan|CARL - Gunggunge utang jangka dawa|RXST (RxSight) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan ClearPoint (CLPT)|Utang jangka dawa perusahaan STXS|Utang jangka dawa perusahaan Neuronetics, Inc (STIM)|Utang jangka dawa perusahaan Sight Sciences, Inc. SGHT|Orchestra BioMed Inc. - Utang jangka dawa perusahaan|ANIK: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan NSPR (InspireMD Inc)|ZJYL: Utang jangka dawa perusahaan|Utang jangka dawa Vivani Medical (VANI)|Utang jangka dawa perusahaan Xtant Medical Holdings, Inc.|NMTC - Tanggungan jangka dawa|Kewajiban jangka dawa perusahaan MODD (Modular Medical)|Utang jangka dawa perusahaan Myomo Inc. (MYO)|Utang jangka dawa perusahaan COCH (Envoy Medical, Inc)|Gunggunge utang jangka dawa Vivos Therapeutics Inc (VVOS)|NVNO - Utang jangka dawa perusahaan|Kewajiban jangka dawa SINT|Tenon Medical (TNON) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan ReWalk Robotics|AMIX (Autonomix Medical Inc.) - Utang jangka dawa perusahaan|Utang jangka dawa INVO Fertility Corp IVF|Utang jangka dawa perusahaan Bone Biologics (BBLG)|axonics.com - Tanggungan utang jangka dawa perusahaan|BIOLASE - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka dawa DYNT (Dynatronics Corp)|FNA: Kewajiban jangka dawa perusahaan|Kewajiban jangka dawa INVO